Contents
Current Drug Targets - Inflammation & Allergy, Volume 1 - Number 1
Diagnosis, Prevention and Treatment of Aspirin-Induced Asthma and Rhinitis
, 1(1): 1 - 11G. Bochenek, K. Banska, Z. Szabo, E. Nizankowska and A. Szczeklik
DOI: 10.2174/1568010023345011
Leptin as a Novel Therapeutic Target for Immune Intervention
, 1(1): 13 - 22G. Matarese, V. Sanna, S. Fontana and S. Zappacosta
DOI: 10.2174/1568010023344931
Oral Tolerance in the Treatment of Rheumatoid Arthritis
, 1(1): 45 - 52Eric A. Toussirot
DOI: 10.2174/1568010023344850
Endocannabinoid Degradation, Endotoxic Shock and Inflammation
, 1(1): 53 - 63M. Maccarrone, M. Bari, N. Battista and A. Finazzi-AgrO
DOI: 10.2174/1568010023344878
An Update of Immunotherapy for Specific Allergies
, 1(1): 65 - 75Susan L. Prescott and Catherine A. Jones
DOI: 10.2174/1568010023344896
Inducible Nitric Oxide Synthase - Time for Reappraisal
, 1(1): 89 - 108Philipp Lirk, Georg Hoffmann and Josef Rieder
DOI: 10.2174/1568010023344913
Chemokines in Allergy
, 1(1): 109 - 116David Chantry and Laurence E. Burgess
DOI: 10.2174/1568010023344995
Mode of Action of Long-Term Low-Dose Macrolide Therapy for Chronic Sinusitis in the Light of Neutrophil Recruitment
, 1(1): 117 - 126Hideaki Suzuki and Katsuhisa Ikeda
DOI: 10.2174/1568010023344832
Webmaster Contact: info@benthamscience.net